AI Proteins: Creating Groundbreaking Treatments on System76 Hardware
Biotech company AI Proteins is at the forefront of revolutionizing medicine through the integration of artificial intelligence (AI) and protein design. They use AI to harness the power of synthetically designed proteins to cure diseases and potentially make medicine more affordable. We recently interviewed AI Proteins about their work and how they use System76 machines and Linux to transform the field of drug discovery.
At the heart of AI Proteins lies a groundbreaking approach called de novo protein design, which leverages the power of AI, synthetic biology, and automation. Unlike traditional protein-based therapies, which are derived from natural sources, de novo protein design allows the creation of entirely new molecules tailored for medicinal purposes. This level of control and precision offers a promising avenue for developing safer, more effective, and purpose-built medicines.